2008
DOI: 10.1016/j.jaad.2008.08.011
|View full text |Cite
|
Sign up to set email alerts
|

Immunosuppression may be present within condyloma acuminata

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
29
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 28 publications
(29 citation statements)
references
References 34 publications
0
29
0
Order By: Relevance
“…This may be because of reduced immunity during pregnancy, changes in hormone levels (for example, elevated progesterone levels), and increased vaginal discharge resulting in a more moist local environment (16).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…This may be because of reduced immunity during pregnancy, changes in hormone levels (for example, elevated progesterone levels), and increased vaginal discharge resulting in a more moist local environment (16).…”
Section: Discussionmentioning
confidence: 99%
“…The wart undergoes necrosis at low temperatures. In addition, cryotherapy treatment is able to induce an antigen-specific immune response and cytokine release (16).…”
Section: Discussionmentioning
confidence: 99%
“…In particular, HPV-positive tonsillar SCCs exhibit an elevated number of FoxP3-positive tumour-infiltrating lymphocytes, when compared to HPV-negative cases [27]. High numbers of regulatory T cells specific for HPV antigens have been identified in cervical cancer [44], as well as higher number of FoxP3-positive T cells in acuminate condylomata than in control tissue [45,46]. There is mounting evidence that the immune response has an important prognostic impact in many HPV-associated tumours and precancerous lesions like CIN and cervical carcinoma or head and neck carcinomas [24,47].…”
Section: Discussionmentioning
confidence: 99%
“…The LCD-array HPV 3.5C uses primer pairs and capture probes specific for HPV types 06, 11, 16, 18, 31, 33, 35, 39, 42, 44, 45, Tumours negative for HPV were examined a second time using a multiplex HPV genotyping assay. GP5+/GP6+ primer-based multiplex PCR and genotyping were performed using Luminex-based multiplexed genotyping (MPG, multiplexed HPV genotyping, Multimetrix, Heidelberg, Germany) for detection of 18 high-risk HPV genotypes (HPV 16,18,26,31,33,35,39,45,51, 52, 53, 56, 58, 59, 66, 68, 73 and 82) and 6 low-risk HPV genotypes (HPV 6, 11, 42, 43, 44 and 70) [13,14] Quantification of lymphocytes The number of labelled lymphocytes was counted for each case in five different representative high-power fields (HPFs) (×40 objective; 22-mm field of view ocular) of tumour tissue and adjacent stroma using an Olympus BX40 microscope (Olympus Europe Holding GmbH, Hamburg, Germany), blinded to the HPV status of tumours.…”
Section: Immunohistologymentioning
confidence: 99%
“…[5,6] This could serve as a tumor antigen, and neoplastic B lymphocytes might be defective in presenting this tumor antigen to the host. We have found deficiencies in antigen presentation in warts, [7] and lymphomas might be deficient in presentation of mutant proteins.…”
mentioning
confidence: 74%